SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Love Hemp announces £4.33 revenue for 2021

    By

    Love Hemp has announced its full financial results for 2021 (year ending 30 June), highlighting a revenue of £4.33m.

    Love Hemp has stated its gross profit was £1.25m with a cash balance of £0.925m following significant market investment. Its investment aligned with the company’s objective of establishing a strong brand-led presence across multiple channels of retail – including wholesale distribution inclusive of £6.3m pre-payments for marketing and licensing agreements.

    The company secured a three-year endorsement agreement with two-time Heavyweight Champion of the World and Olympic gold medallist Anthony Joshua OBE, which saw the champion become a shareholder. Joshua spearheaded Love Hemp’s new national campaign which is featuring across national media channels including ITV, All 4 and Sky, The Metro, and on outdoor advertising formats in London, Manchester, Liverpool, and the Northeast.

    The company has highlighted understanding its consumers as key to the momentum of its brand building.

    CEO, Tony Calamita, commented: “Love Hemp Group has undergone major changes during the period. Embedding a new team, aligning the business with its new regulatory reporting obligations, and establishing appropriate corporate governance measures have been our priority for the Company’s corporate maturation and planned move to the Main Market of the London Stock Exchange. 

    “These corporate changes have been alongside delivering growth in revenue, attracting new customers, developing new retail relationships and securing partnerships with leading organisations and individuals. A huge amount has been achieved to date and important preparations have been made for the Company’s growth trajectory.

    “This next phase is focused on building brand visibility and loyalty and creating a distinctive position for Love Hemp in the burgeoning CBD wellness sector. Investment in brand-building commenced in November 2021 with the launch of our first national media campaign with our investor and ambassador Anthony Joshua.

    “This campaign was the first step in leveraging our outstanding partnerships which, coupled with impactful marketing, is a crucial part of our growth strategy. Positioning outdoor adverts near our key retail outlets has already resulted in significant orders from both Boots and Holland & Barrett. We have also attracted new customers to lovehemp.com in November, with 35 per cent of November orders coming from first time buyers.

    “In addition to building the brand, visibility it is crucial for us to grow the value of the brand. We have moved away from regular discounting and will be implementing new marketing initiatives in the New Year to drive value. We have already seen the positive impact of this change in our Black Friday sale which ran for one week rather than the whole of November as per previous years. 

    “Revenue from lovehemp.com increased 12.6 per cent in November compared to average revenue of the previous 10 months, and this uplift was achieved while moving away from discount led promotions other than the Black Friday week.

    “Key to the momentum of brand building is understanding our consumers. Our revised marketing strategy will see us pivot towards a focus on the consumer use cases of sleep, stress, anxiety, recovery, and pain. Investment in data driven marketing will enable us to better understand who our consumers are and their purchasing behaviour, which will in turn improve targeting and grow our market share amongst key audiences. 

    “Enabled by our data driven decisions, the New Year will also see the launch of multiple new products. These new products target new audiences and new distribution channels. These new products have all been developed by our in-house New Product Development team in our new premises in Manchester.

    “A focus on consumer use cases, investment in brand building through partnerships, data driven digital marketing and new product development help deliver a robust, distinctive and informed offering. We believe this is unique in the CBD wellness space and that these developments, in addition to the strong revenue, growing customer base and established sales channels, provide Love Hemp with a platform from which to become a globally recognised and trusted brand.

    “In what has been a challenging phase in the company’s development we look forward to entering the New Year with refreshed purpose and delivering strong results throughout the remainder of the current financial year.”

    The company recently announced it expects further growth once it is launched on Amazon in Q1 2022, and executes a new subscription model and overseas expansion into the US, Europe and Japan.

    [activecampaign form=31]

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free